2022
DOI: 10.3389/fimmu.2022.1065927
|View full text |Cite
|
Sign up to set email alerts
|

Fatty acid metabolism is related to the immune microenvironment changes of gastric cancer and RGS2 is a new tumor biomarker

Abstract: BackgroundAlterations in lipid metabolism promote tumor progression. However, the role of lipid metabolism in the occurrence and development of gastric cancer have not been fully clarifiedMethodHere, genes that are related to fatty acid metabolism and differentially-expressed between normal and gastric cancer tissues were identified in the TCGA-STAD cohort. The intersection of identified differentially-expressed genes with Geneset was determined to obtain 78 fatty acid metabolism-related genes. The ConsensusCl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
22
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 18 publications
(23 citation statements)
references
References 44 publications
(38 reference statements)
1
22
0
Order By: Relevance
“…ML approaches also contributed to the development of a fatty acid prognostic risk model (FARS), which showed promising prognostic efficacy. Through single‐cell analysis, differentially expressed genes and fatty acid metabolism in gastric tumour tissues were analysed, leading to the discovery of a novel biomarker, the RGS2 gene 32 . These ML methods have proven valuable in predicting treatment response, identifying prognostic markers and uncovering biological insights, offering the potential for improving tumour prognosis and clinical decision‐making.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…ML approaches also contributed to the development of a fatty acid prognostic risk model (FARS), which showed promising prognostic efficacy. Through single‐cell analysis, differentially expressed genes and fatty acid metabolism in gastric tumour tissues were analysed, leading to the discovery of a novel biomarker, the RGS2 gene 32 . These ML methods have proven valuable in predicting treatment response, identifying prognostic markers and uncovering biological insights, offering the potential for improving tumour prognosis and clinical decision‐making.…”
Section: Resultsmentioning
confidence: 99%
“…(2022) found regulator of G protein signalling 2 (RGS2) to be a promising immunotherapy target, and Jiang et al. (2022) identified PD‐1 expression in CD8+ T cells as a predictive marker for treatment response 27,32 . Kang et al.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations